SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer

NCT06666166 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Carcinoma
Advanced Gastroesophageal Junction Adenocarcinoma
Advanced Colorectal Cancer

Interventions

DRUG: SHR-A1811 & Apartinib

Sponsor

Yunpeng Liu

Collaborators

[object Object]